<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1988-01-01" modified="2020-10-07" version="246">
<accession>P06748</accession>
<accession>A8K3N7</accession>
<accession>B5BU00</accession>
<accession>D3DQL6</accession>
<accession>P08693</accession>
<accession>Q12826</accession>
<accession>Q13440</accession>
<accession>Q13441</accession>
<accession>Q14115</accession>
<accession>Q5EU94</accession>
<accession>Q5EU95</accession>
<accession>Q5EU96</accession>
<accession>Q5EU97</accession>
<accession>Q5EU98</accession>
<accession>Q5EU99</accession>
<accession>Q6V962</accession>
<accession>Q8WTW5</accession>
<accession>Q96AT6</accession>
<accession>Q96DC4</accession>
<accession>Q96EA5</accession>
<accession>Q9BYG9</accession>
<accession>Q9UDJ7</accession>
<name>NPM_HUMAN</name>
<protein>
<recommendedName>
<fullName>Nucleophosmin</fullName>
<shortName>NPM</shortName>
</recommendedName>
<alternativeName>
<fullName>Nucleolar phosphoprotein B23</fullName>
</alternativeName>
<alternativeName>
<fullName>Nucleolar protein NO38</fullName>
</alternativeName>
<alternativeName>
<fullName>Numatrin</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">NPM1</name>
<name type="synonym">NPM</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1989" name="Biochemistry" volume="28" first="1033" last="1039">
<title>Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth.</title>
<authorList>
<person name="Chan W.-Y."/>
<person name="Liu Q.R."/>
<person name="Borjigin J."/>
<person name="Busch H."/>
<person name="Rennert O.M."/>
<person name="Tease L.A."/>
<person name="Chan P.-K."/>
</authorList>
<dbReference type="PubMed" id="2713355"/>
<dbReference type="DOI" id="10.1021/bi00429a017"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1989" name="Biochem. Biophys. Res. Commun." volume="163" first="72" last="78">
<title>The nucleotide sequence of a human cDNA encoding the highly conserved nucleolar phosphoprotein B23.</title>
<authorList>
<person name="Li X."/>
<person name="McNeilage L.J."/>
<person name="Whittingham S."/>
</authorList>
<dbReference type="PubMed" id="2775293"/>
<dbReference type="DOI" id="10.1016/0006-291x(89)92100-1"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>B-cell lymphoma</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1989" name="Biochem. Biophys. Res. Commun." volume="164" first="176" last="184">
<title>Isolation and characterization of a molecular cDNA clone of a human mRNA from interferon-treated cells encoding nucleolar protein B23, numatrin.</title>
<authorList>
<person name="Zhang X.T."/>
<person name="Thomis D.C."/>
<person name="Samuel C.E."/>
</authorList>
<dbReference type="PubMed" id="2478125"/>
<dbReference type="DOI" id="10.1016/0006-291x(89)91699-9"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Amnion</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1997" name="Nucleic Acids Res." volume="25" first="1225" last="1232">
<title>Isolation and characterization of the human nucleophosmin/B23 (NPM) gene: identification of the YY1 binding site at the 5' enhancer region.</title>
<authorList>
<person name="Chan P.-K."/>
<person name="Chan F.Y."/>
<person name="Morris S.W."/>
<person name="Xie Z."/>
</authorList>
<dbReference type="PubMed" id="9092633"/>
<dbReference type="DOI" id="10.1093/nar/25.6.1225"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1)</scope>
</reference>
<reference key="5">
<citation type="submission" date="2000-04" db="EMBL/GenBank/DDBJ databases">
<title>Human homologue of Rat B23.2.</title>
<authorList>
<person name="Okuwaki M."/>
<person name="Nagata K."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2005" name="N. Engl. J. Med." volume="352" first="254" last="266">
<title>Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.</title>
<authorList>
<person name="Falini B."/>
<person name="Mecucci C."/>
<person name="Tiacci E."/>
<person name="Alcalay M."/>
<person name="Rosati R."/>
<person name="Pasqualucci L."/>
<person name="La Starza R."/>
<person name="Diverio D."/>
<person name="Colombo E."/>
<person name="Santucci A."/>
<person name="Bigerna B."/>
<person name="Pacini R."/>
<person name="Pucciarini A."/>
<person name="Liso A."/>
<person name="Vignetti M."/>
<person name="Fazi P."/>
<person name="Meani N."/>
<person name="Pettirossi V."/>
<person name="Saglio G."/>
<person name="Mandelli F."/>
<person name="Lo-Coco F."/>
<person name="Pelicci P.-G."/>
<person name="Martelli M.F."/>
</authorList>
<dbReference type="PubMed" id="15659725"/>
<dbReference type="DOI" id="10.1056/nejmoa041974"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INVOLVEMENT IN ACUTE MYELOGENOUS LEUKEMIA</scope>
<source>
<tissue>Bone marrow</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2006" name="Lancet Oncol." volume="7" first="350" last="352">
<title>Cytoplasmic nucleophosmin in myeloid sarcoma occurring 20 years after diagnosis of acute myeloid leukaemia.</title>
<authorList>
<person name="Bolli N."/>
<person name="Galimberti S."/>
<person name="Martelli M.P."/>
<person name="Tabarrini A."/>
<person name="Roti G."/>
<person name="Mecucci C."/>
<person name="Martelli M.F."/>
<person name="Petrini M."/>
<person name="Falini B."/>
</authorList>
<dbReference type="PubMed" id="16574551"/>
<dbReference type="DOI" id="10.1016/s1470-2045(06)70661-1"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="8">
<citation type="submission" date="2003-07" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of a new transcript of nucleophosmin in testis.</title>
<authorList>
<person name="Lu L."/>
<person name="Huang X.Y."/>
<person name="Yin L.L."/>
<person name="Xu M."/>
<person name="Li J.M."/>
<person name="Zhou Z.M."/>
<person name="Sha J.H."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="9">
<citation type="submission" date="2003-05" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Embryo</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2008" name="Nat. Methods" volume="5" first="1011" last="1017">
<title>Human protein factory for converting the transcriptome into an in vitro-expressed proteome.</title>
<authorList>
<person name="Goshima N."/>
<person name="Kawamura Y."/>
<person name="Fukumoto A."/>
<person name="Miura A."/>
<person name="Honma R."/>
<person name="Satoh R."/>
<person name="Wakamatsu A."/>
<person name="Yamamoto J."/>
<person name="Kimura K."/>
<person name="Nishikawa T."/>
<person name="Andoh T."/>
<person name="Iida Y."/>
<person name="Ishikawa K."/>
<person name="Ito E."/>
<person name="Kagawa N."/>
<person name="Kaminaga C."/>
<person name="Kanehori K."/>
<person name="Kawakami B."/>
<person name="Kenmochi K."/>
<person name="Kimura R."/>
<person name="Kobayashi M."/>
<person name="Kuroita T."/>
<person name="Kuwayama H."/>
<person name="Maruyama Y."/>
<person name="Matsuo K."/>
<person name="Minami K."/>
<person name="Mitsubori M."/>
<person name="Mori M."/>
<person name="Morishita R."/>
<person name="Murase A."/>
<person name="Nishikawa A."/>
<person name="Nishikawa S."/>
<person name="Okamoto T."/>
<person name="Sakagami N."/>
<person name="Sakamoto Y."/>
<person name="Sasaki Y."/>
<person name="Seki T."/>
<person name="Sono S."/>
<person name="Sugiyama A."/>
<person name="Sumiya T."/>
<person name="Takayama T."/>
<person name="Takayama Y."/>
<person name="Takeda H."/>
<person name="Togashi T."/>
<person name="Yahata K."/>
<person name="Yamada H."/>
<person name="Yanagisawa Y."/>
<person name="Endo Y."/>
<person name="Imamoto F."/>
<person name="Kisu Y."/>
<person name="Tanaka S."/>
<person name="Isogai T."/>
<person name="Imai J."/>
<person name="Watanabe S."/>
<person name="Nomura N."/>
</authorList>
<dbReference type="PubMed" id="19054851"/>
<dbReference type="DOI" id="10.1038/nmeth.1273"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="12">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3)</scope>
<source>
<tissue>Bone marrow</tissue>
<tissue>Brain</tissue>
<tissue>Kidney</tissue>
<tissue>Lung</tissue>
<tissue>Prostate</tissue>
<tissue>Testis</tissue>
<tissue>Urinary bladder</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="1996" name="Blood" volume="87" first="882" last="886">
<title>The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion.</title>
<authorList>
<person name="Redner R.L."/>
<person name="Rush E.A."/>
<person name="Faas S."/>
<person name="Rudert W.A."/>
<person name="Corey S.J."/>
</authorList>
<dbReference type="PubMed" id="8562957"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-133</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH RARA</scope>
<source>
<tissue>Bone marrow</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="1994" name="Science" volume="263" first="1281" last="1284">
<title>Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.</title>
<authorList>
<person name="Morris S.W."/>
<person name="Kirstein M.N."/>
<person name="Valentine M.B."/>
<person name="Dittmer K.G."/>
<person name="Shapiro D.N."/>
<person name="Saltman D.L."/>
<person name="Look A.T."/>
</authorList>
<dbReference type="PubMed" id="8122112"/>
<dbReference type="DOI" id="10.1126/science.8122112"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-117</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH ALK</scope>
<source>
<tissue>T-cell lymphoma</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="1996" name="Proc. Natl. Acad. Sci. U.S.A." volume="93" first="4181" last="4186">
<title>Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5).</title>
<authorList>
<person name="Fujimoto J."/>
<person name="Shiota M."/>
<person name="Iwahara T."/>
<person name="Seki N."/>
<person name="Satoh H."/>
<person name="Mori S."/>
<person name="Yamamoto T."/>
</authorList>
<dbReference type="PubMed" id="8633037"/>
<dbReference type="DOI" id="10.1073/pnas.93.9.4181"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-117</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH ALK</scope>
<source>
<tissue>Lymphoma</tissue>
</source>
</reference>
<reference key="17">
<citation type="submission" date="2009-03" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
<person name="Waridel P."/>
<person name="Quadroni M."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 1-24; 33-101; 104-141; 240-248 AND 278-291</scope>
<scope>ACETYLATION AT MET-1</scope>
<scope>PHOSPHORYLATION AT SER-125</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="1989" name="Nucleic Acids Res." volume="17" first="10112" last="10112">
<title>Nucleotide sequence of a cDNA clone representing a third allele of human protein B23.</title>
<authorList>
<person name="Hale T.K."/>
<person name="Mansfield B.C."/>
</authorList>
<dbReference type="PubMed" id="2602120"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 15-294 (ISOFORM 1)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="1997" name="Electrophoresis" volume="18" first="605" last="613">
<title>A two-dimensional gel database of human colon carcinoma proteins.</title>
<authorList>
<person name="Ji H."/>
<person name="Reid G.E."/>
<person name="Moritz R.L."/>
<person name="Eddes J.S."/>
<person name="Burgess A.W."/>
<person name="Simpson R.J."/>
</authorList>
<dbReference type="PubMed" id="9150948"/>
<dbReference type="DOI" id="10.1002/elps.1150180344"/>
</citation>
<scope>PROTEIN SEQUENCE OF 33-54</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="1993" name="J. Biol. Chem." volume="268" first="13930" last="13934">
<title>Nucleolar targeting signal of Rex protein of human T-cell leukemia virus type I specifically binds to nucleolar shuttle protein B-23.</title>
<authorList>
<person name="Adachi Y."/>
<person name="Copeland T.D."/>
<person name="Hatanaka M."/>
<person name="Oroszlan S."/>
</authorList>
<dbReference type="PubMed" id="8314759"/>
</citation>
<scope>PROTEIN SEQUENCE OF 34-42; 50-67; 137-151; 218-227; 252-266 AND 277-286 (ISOFORM 1)</scope>
<scope>INTERACTION WITH HTLV1 REX PROTEIN (MICROBIAL INFECTION)</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="41709" last="41717">
<title>Nucleophosmin interacts with and inhibits the catalytic function of eukaryotic initiation factor 2 kinase PKR.</title>
<authorList>
<person name="Pang Q."/>
<person name="Christianson T.A."/>
<person name="Koretsky T."/>
<person name="Carlson H."/>
<person name="David L."/>
<person name="Keeble W."/>
<person name="Faulkner G.R."/>
<person name="Speckhart A."/>
<person name="Bagby G.C."/>
</authorList>
<dbReference type="PubMed" id="12882984"/>
<dbReference type="DOI" id="10.1074/jbc.m301392200"/>
</citation>
<scope>PROTEIN SEQUENCE OF 33-42; 213-221; 251-257 AND 268-274</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH EIF2AK2</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1986" name="J. Biol. Chem." volume="261" first="1868" last="1872">
<title>Amino acid sequence of protein B23 phosphorylation site.</title>
<authorList>
<person name="Chan P.-K."/>
<person name="Aldrich M.B."/>
<person name="Cook R.G."/>
<person name="Busch H."/>
</authorList>
<dbReference type="PubMed" id="3944116"/>
</citation>
<scope>PROTEIN SEQUENCE OF 115-134</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1986" name="J. Biol. Chem." volume="261" first="14335" last="14341">
<title>Amino acid sequence of a specific antigenic peptide of protein B23.</title>
<authorList>
<person name="Chan P.-K."/>
<person name="Chan W.-Y."/>
<person name="Yung B.Y.M."/>
<person name="Cook R.G."/>
<person name="Aldrich M.B."/>
<person name="Ku D."/>
<person name="Goldknopf I.L."/>
<person name="Busch H."/>
</authorList>
<dbReference type="PubMed" id="2429957"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 213-294 (ISOFORM 1)</scope>
<scope>PROTEIN SEQUENCE OF 227-294</scope>
</reference>
<reference key="24">
<citation type="journal article" date="1995" name="Radiat. Res." volume="143" first="158" last="164">
<title>Modification of nucleolar protein B23 after exposure to ionizing radiation.</title>
<authorList>
<person name="Ramsamooj P."/>
<person name="Notario V."/>
<person name="Dritschilo A."/>
</authorList>
<dbReference type="PubMed" id="7631008"/>
<dbReference type="DOI" id="10.2307/3579152"/>
</citation>
<scope>ADP-RIBOSYLATION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="1996" name="Oncogene" volume="12" first="265" last="275">
<title>The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1.</title>
<authorList>
<person name="Yoneda-Kato N."/>
<person name="Look A.T."/>
<person name="Kirstein M.N."/>
<person name="Valentine M.B."/>
<person name="Raimondi S.C."/>
<person name="Cohen K.J."/>
<person name="Carroll A.J."/>
<person name="Morris S.W."/>
</authorList>
<dbReference type="PubMed" id="8570204"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH MLF1</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2000" name="Cell" volume="103" first="127" last="140">
<title>Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication.</title>
<authorList>
<person name="Okuda M."/>
<person name="Horn H.F."/>
<person name="Tarapore P."/>
<person name="Tokuyama Y."/>
<person name="Smulian A.G."/>
<person name="Chan P.K."/>
<person name="Knudsen E.S."/>
<person name="Hofmann I.A."/>
<person name="Snyder J.D."/>
<person name="Bove K.E."/>
<person name="Fukasawa K."/>
</authorList>
<dbReference type="PubMed" id="11051553"/>
<dbReference type="DOI" id="10.1016/s0092-8674(00)00093-3"/>
</citation>
<scope>PHOSPHORYLATION BY CDK2</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="25166" last="25175">
<title>The nucleolar phosphoprotein B23 interacts with hepatitis delta antigens and modulates the hepatitis delta virus RNA replication.</title>
<authorList>
<person name="Huang W.H."/>
<person name="Yung B.Y."/>
<person name="Syu W.J."/>
<person name="Lee Y.H."/>
</authorList>
<dbReference type="PubMed" id="11309377"/>
<dbReference type="DOI" id="10.1074/jbc.m010087200"/>
</citation>
<scope>INTERACTION WITH HEPATITIS DELTA VIRUS S-HDAG (MICROBIAL INFECTION)</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2002" name="Mol. Biol. Cell" volume="13" first="2016" last="2030">
<title>The RNA binding activity of a ribosome biogenesis factor, nucleophosmin/B23, is modulated by phosphorylation with a cell cycle-dependent kinase and by association with its subtype.</title>
<authorList>
<person name="Okuwaki M."/>
<person name="Tsujimoto M."/>
<person name="Nagata K."/>
</authorList>
<dbReference type="PubMed" id="12058066"/>
<dbReference type="DOI" id="10.1091/mbc.02-03-0036"/>
</citation>
<scope>PHOSPHORYLATION AT THR-199; THR-219 AND THR-237</scope>
<scope>MUTAGENESIS OF THR-199; THR-219; THR-234 AND THR-237</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2002" name="Mol. Biol. Cell" volume="13" first="4100" last="4109">
<title>Functional proteomic analysis of human nucleolus.</title>
<authorList>
<person name="Scherl A."/>
<person name="Coute Y."/>
<person name="Deon C."/>
<person name="Calle A."/>
<person name="Kindbeiter K."/>
<person name="Sanchez J.-C."/>
<person name="Greco A."/>
<person name="Hochstrasser D.F."/>
<person name="Diaz J.-J."/>
</authorList>
<dbReference type="PubMed" id="12429849"/>
<dbReference type="DOI" id="10.1091/mbc.e02-05-0271"/>
</citation>
<scope>SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2002" name="Oncogene" volume="21" first="6170" last="6174">
<title>The role of nucleophosmin in centrosome duplication.</title>
<authorList>
<person name="Okuda M."/>
</authorList>
<dbReference type="PubMed" id="12214246"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2003" name="Nature" volume="426" first="570" last="574">
<title>Proteomic characterization of the human centrosome by protein correlation profiling.</title>
<authorList>
<person name="Andersen J.S."/>
<person name="Wilkinson C.J."/>
<person name="Mayor T."/>
<person name="Mortensen P."/>
<person name="Nigg E.A."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="14654843"/>
<dbReference type="DOI" id="10.1038/nature02166"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Lymphoblast</tissue>
</source>
</reference>
<reference key="32">
<citation type="journal article" date="2004" name="FEBS Lett." volume="575" first="112" last="118">
<title>Nek2A kinase regulates the localization of numatrin to centrosome in mitosis.</title>
<authorList>
<person name="Yao J."/>
<person name="Fu C."/>
<person name="Ding X."/>
<person name="Guo Z."/>
<person name="Zenreski A."/>
<person name="Chen Y."/>
<person name="Ahmed K."/>
<person name="Liao J."/>
<person name="Dou Z."/>
<person name="Yao X."/>
</authorList>
<dbReference type="PubMed" id="15388344"/>
<dbReference type="DOI" id="10.1016/j.febslet.2004.08.047"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH NEK2</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="35726" last="35734">
<title>B23/nucleophosmin serine 4 phosphorylation mediates mitotic functions of polo-like kinase 1.</title>
<authorList>
<person name="Zhang H."/>
<person name="Shi X."/>
<person name="Paddon H."/>
<person name="Hampong M."/>
<person name="Dai W."/>
<person name="Pelech S."/>
</authorList>
<dbReference type="PubMed" id="15190079"/>
<dbReference type="DOI" id="10.1074/jbc.m403264200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-4 BY PLK1</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2005" name="Hum. Mol. Genet." volume="14" first="1183" last="1197">
<title>RPGR ORF15 isoform co-localizes with RPGRIP1 at centrioles and basal bodies and interacts with nucleophosmin.</title>
<authorList>
<person name="Shu X."/>
<person name="Fry A.M."/>
<person name="Tulloch B."/>
<person name="Manson F.D."/>
<person name="Crabb J.W."/>
<person name="Khanna H."/>
<person name="Faragher A.J."/>
<person name="Lennon A."/>
<person name="He S."/>
<person name="Trojan P."/>
<person name="Giessl A."/>
<person name="Wolfrum U."/>
<person name="Vervoort R."/>
<person name="Swaroop A."/>
<person name="Wright A.F."/>
</authorList>
<dbReference type="PubMed" id="15772089"/>
<dbReference type="DOI" id="10.1093/hmg/ddi129"/>
</citation>
<scope>INTERACTION WITH RPGR</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2005" name="Mol. Cell. Biol." volume="25" first="7534" last="7545">
<title>Human histone chaperone nucleophosmin enhances acetylation-dependent chromatin transcription.</title>
<authorList>
<person name="Swaminathan V."/>
<person name="Kishore A.H."/>
<person name="Febitha K.K."/>
<person name="Kundu T.K."/>
</authorList>
<dbReference type="PubMed" id="16107701"/>
<dbReference type="DOI" id="10.1128/mcb.25.17.7534-7545.2005"/>
</citation>
<scope>ACETYLATION AT LYS-212; LYS-229; LYS-230; LYS-250; LYS-257 AND LYS-292</scope>
<scope>FUNCTION AS A CHAPERONE</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="7689" last="7694">
<title>Sumoylation induced by the Arf tumor suppressor: a p53-independent function.</title>
<authorList>
<person name="Tago K."/>
<person name="Chiocca S."/>
<person name="Sherr C.J."/>
</authorList>
<dbReference type="PubMed" id="15897463"/>
<dbReference type="DOI" id="10.1073/pnas.0502978102"/>
</citation>
<scope>SUMOYLATION AT LYS-230 AND LYS-263</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-70 AND THR-95</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="38">
<citation type="journal article" date="2006" name="Mol. Cell" volume="23" first="607" last="618">
<title>Substrate and functional diversity of lysine acetylation revealed by a proteomics survey.</title>
<authorList>
<person name="Kim S.C."/>
<person name="Sprung R."/>
<person name="Chen Y."/>
<person name="Xu Y."/>
<person name="Ball H."/>
<person name="Pei J."/>
<person name="Cheng T."/>
<person name="Kho Y."/>
<person name="Xiao H."/>
<person name="Xiao L."/>
<person name="Grishin N.V."/>
<person name="White M."/>
<person name="Yang X.-J."/>
<person name="Zhao Y."/>
</authorList>
<dbReference type="PubMed" id="16916647"/>
<dbReference type="DOI" id="10.1016/j.molcel.2006.06.026"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-150; LYS-154 AND LYS-212</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="39">
<citation type="journal article" date="2006" name="Mol. Cell. Biol." volume="26" first="9016" last="9034">
<title>Interaction between ROCK II and nucleophosmin/B23 in the regulation of centrosome duplication.</title>
<authorList>
<person name="Ma Z."/>
<person name="Kanai M."/>
<person name="Kawamura K."/>
<person name="Kaibuchi K."/>
<person name="Ye K."/>
<person name="Fukasawa K."/>
</authorList>
<dbReference type="PubMed" id="17015463"/>
<dbReference type="DOI" id="10.1128/mcb.01383-06"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ROCK2</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2007" name="J. Proteome Res." volume="6" first="4150" last="4162">
<title>Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.</title>
<authorList>
<person name="Yu L.R."/>
<person name="Zhu Z."/>
<person name="Chan K.C."/>
<person name="Issaq H.J."/>
<person name="Dimitrov D.S."/>
<person name="Veenstra T.D."/>
</authorList>
<dbReference type="PubMed" id="17924679"/>
<dbReference type="DOI" id="10.1021/pr070152u"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-70; THR-199 AND SER-254</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="41">
<citation type="journal article" date="2007" name="Mol. Biol. Cell" volume="18" first="1107" last="1117">
<title>Aurora-B regulates RNA methyltransferase NSUN2.</title>
<authorList>
<person name="Sakita-Suto S."/>
<person name="Kanda A."/>
<person name="Suzuki F."/>
<person name="Sato S."/>
<person name="Takata T."/>
<person name="Tatsuka M."/>
</authorList>
<dbReference type="PubMed" id="17215513"/>
<dbReference type="DOI" id="10.1091/mbc.e06-11-1021"/>
</citation>
<scope>INTERACTION WITH NSUN2</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2008" name="EMBO Rep." volume="9" first="273" last="279">
<title>The nucleolar SUMO-specific protease SENP3 reverses SUMO modification of nucleophosmin and is required for rRNA processing.</title>
<authorList>
<person name="Haindl M."/>
<person name="Harasim T."/>
<person name="Eick D."/>
<person name="Muller S."/>
</authorList>
<dbReference type="PubMed" id="18259216"/>
<dbReference type="DOI" id="10.1038/embor.2008.3"/>
</citation>
<scope>INTERACTION WITH SENP3</scope>
<scope>MUTAGENESIS OF LYS-263</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2008" name="J. Cell Biol." volume="183" first="589" last="595">
<title>Nucleolar protein B23/nucleophosmin regulates the vertebrate SUMO pathway through SENP3 and SENP5 proteases.</title>
<authorList>
<person name="Yun C."/>
<person name="Wang Y."/>
<person name="Mukhopadhyay D."/>
<person name="Backlund P."/>
<person name="Kolli N."/>
<person name="Yergey A."/>
<person name="Wilkinson K.D."/>
<person name="Dasso M."/>
</authorList>
<dbReference type="PubMed" id="19015314"/>
<dbReference type="DOI" id="10.1083/jcb.200807185"/>
</citation>
<scope>INTERACTION WITH SENP3</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2008" name="J. Biochem." volume="143" first="441" last="448">
<title>The structure and functions of NPM1/Nucleophosmin/B23, a multifunctional nucleolar acidic protein.</title>
<authorList>
<person name="Okuwaki M."/>
</authorList>
<dbReference type="PubMed" id="18024471"/>
<dbReference type="DOI" id="10.1093/jb/mvm222"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-70; SER-125 AND THR-279</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="46">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-70 AND SER-125</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="47">
<citation type="journal article" date="2008" name="Mol. Cell. Biol." volume="28" first="7050" last="7065">
<title>Nucleophosmin serves as a rate-limiting nuclear export chaperone for the Mammalian ribosome.</title>
<authorList>
<person name="Maggi L.B. Jr."/>
<person name="Kuchenruether M."/>
<person name="Dadey D.Y."/>
<person name="Schwope R.M."/>
<person name="Grisendi S."/>
<person name="Townsend R.R."/>
<person name="Pandolfi P.P."/>
<person name="Weber J.D."/>
</authorList>
<dbReference type="PubMed" id="18809582"/>
<dbReference type="DOI" id="10.1128/mcb.01548-07"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-70; THR-75; THR-95; SER-125; SER-139; THR-234; THR-237 AND SER-243</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="49">
<citation type="journal article" date="2008" name="Proteomics" volume="8" first="1346" last="1361">
<title>Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography.</title>
<authorList>
<person name="Han G."/>
<person name="Ye M."/>
<person name="Zhou H."/>
<person name="Jiang X."/>
<person name="Feng S."/>
<person name="Jiang X."/>
<person name="Tian R."/>
<person name="Wan D."/>
<person name="Zou H."/>
<person name="Gu J."/>
</authorList>
<dbReference type="PubMed" id="18318008"/>
<dbReference type="DOI" id="10.1002/pmic.200700884"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="50">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="28660" last="28673">
<title>The metastasis efficiency modifier ribosomal RNA processing 1 homolog B (RRP1B) is a chromatin-associated factor.</title>
<authorList>
<person name="Crawford N.P."/>
<person name="Yang H."/>
<person name="Mattaini K.R."/>
<person name="Hunter K.W."/>
</authorList>
<dbReference type="PubMed" id="19710015"/>
<dbReference type="DOI" id="10.1074/jbc.m109.023457"/>
</citation>
<scope>INTERACTION WITH RRP1B</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2009" name="J. Cell Sci." volume="122" first="678" last="686">
<title>Nucleolar structure and function are regulated by the deubiquitylating enzyme USP36.</title>
<authorList>
<person name="Endo A."/>
<person name="Matsumoto M."/>
<person name="Inada T."/>
<person name="Yamamoto A."/>
<person name="Nakayama K.I."/>
<person name="Kitamura N."/>
<person name="Komada M."/>
</authorList>
<dbReference type="PubMed" id="19208757"/>
<dbReference type="DOI" id="10.1242/jcs.044461"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>UBIQUITINATION</scope>
<scope>DEUBIQUITINATION BY USP36</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2009" name="Mol. Cell. Biol." volume="29" first="1834" last="1854">
<title>APE1/Ref-1 interacts with NPM1 within nucleoli and plays a role in the rRNA quality control process.</title>
<authorList>
<person name="Vascotto C."/>
<person name="Fantini D."/>
<person name="Romanello M."/>
<person name="Cesaratto L."/>
<person name="Deganuto M."/>
<person name="Leonardi A."/>
<person name="Radicella J.P."/>
<person name="Kelley M.R."/>
<person name="D'Ambrosio C."/>
<person name="Scaloni A."/>
<person name="Quadrifoglio F."/>
<person name="Tell G."/>
</authorList>
<dbReference type="PubMed" id="19188445"/>
<dbReference type="DOI" id="10.1128/mcb.01337-08"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH APEX1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.m800588-mcp200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-70 AND SER-125</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="56">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-32; LYS-150; LYS-257; LYS-267 AND LYS-273</scope>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-257 (ISOFORM 3)</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2010" name="EMBO J." volume="29" first="897" last="909">
<title>Nucleolar retention of a translational C/EBPalpha isoform stimulates rDNA transcription and cell size.</title>
<authorList>
<person name="Muller C."/>
<person name="Bremer A."/>
<person name="Schreiber S."/>
<person name="Eichwald S."/>
<person name="Calkhoven C.F."/>
</authorList>
<dbReference type="PubMed" id="20075868"/>
<dbReference type="DOI" id="10.1038/emboj.2009.404"/>
</citation>
<scope>INTERACTION WITH CEBPA</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="12695" last="12705">
<title>Methylation of ribosomal protein S10 by protein-arginine methyltransferase 5 regulates ribosome biogenesis.</title>
<authorList>
<person name="Ren J."/>
<person name="Wang Y."/>
<person name="Liang Y."/>
<person name="Zhang Y."/>
<person name="Bao S."/>
<person name="Xu Z."/>
</authorList>
<dbReference type="PubMed" id="20159986"/>
<dbReference type="DOI" id="10.1074/jbc.m110.103911"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH RPS10</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2010" name="Mol. Biol. Cell" volume="21" first="4212" last="4226">
<title>RRP1B targets PP1 to mammalian cell nucleoli and is associated with pre-60S ribosomal subunits.</title>
<authorList>
<person name="Chamousset D."/>
<person name="De Wever V."/>
<person name="Moorhead G.B."/>
<person name="Chen Y."/>
<person name="Boisvert F.M."/>
<person name="Lamond A.I."/>
<person name="Trinkle-Mulcahy L."/>
</authorList>
<dbReference type="PubMed" id="20926688"/>
<dbReference type="DOI" id="10.1091/mbc.e10-04-0287"/>
</citation>
<scope>INTERACTION WITH RRP1B</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2010" name="PLoS ONE" volume="5" first="E9849" last="E9849">
<title>Polo-like kinase 2-dependent phosphorylation of NPM/B23 on serine 4 triggers centriole duplication.</title>
<authorList>
<person name="Krause A."/>
<person name="Hoffmann I."/>
</authorList>
<dbReference type="PubMed" id="20352051"/>
<dbReference type="DOI" id="10.1371/journal.pone.0009849"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT SER-4 BY PLK2</scope>
<scope>MUTAGENESIS OF SER-4; THR-95; SER-125 AND THR-199</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2010" name="PLoS Pathog." volume="6" first="E1000818" last="E1000818">
<title>Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.</title>
<authorList>
<person name="Sarek G."/>
<person name="Jaerviluoma A."/>
<person name="Moore H.M."/>
<person name="Tojkander S."/>
<person name="Vartia S."/>
<person name="Biberfeld P."/>
<person name="Laiho M."/>
<person name="Ojala P.M."/>
</authorList>
<dbReference type="PubMed" id="20333249"/>
<dbReference type="DOI" id="10.1371/journal.ppat.1000818"/>
</citation>
<scope>PHOSPHORYLATION AT THR-199 BY CDK6</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4; SER-10; SER-70; THR-95; SER-125; SER-137; SER-139; THR-199; SER-242; SER-243; SER-260 AND THR-279</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-254 (ISOFORM 3)</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="63">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2011" name="Cancer Res." volume="71" first="68" last="77">
<title>BRCA2 and nucleophosmin coregulate centrosome amplification and form a complex with the Rho effector kinase ROCK2.</title>
<authorList>
<person name="Wang H.F."/>
<person name="Takenaka K."/>
<person name="Nakanishi A."/>
<person name="Miki Y."/>
</authorList>
<dbReference type="PubMed" id="21084279"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-10-0030"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH BRCA2</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="42758" last="42769">
<title>New centromeric component CENP-W is an RNA-associated nuclear matrix protein that interacts with nucleophosmin/B23 protein.</title>
<authorList>
<person name="Chun Y."/>
<person name="Park B."/>
<person name="Koh W."/>
<person name="Lee S."/>
<person name="Cheon Y."/>
<person name="Kim R."/>
<person name="Che L."/>
<person name="Lee S."/>
</authorList>
<dbReference type="PubMed" id="22002061"/>
<dbReference type="DOI" id="10.1074/jbc.m111.228411"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH CENPW</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4; SER-70; SER-125; SER-227; SER-243 AND SER-254</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2012" name="J. Biol. Chem." volume="287" first="19599" last="19609">
<title>Nucleophosmin (NPM1/B23) interacts with activating transcription factor 5 (ATF5) protein and promotes proteasome- and caspase-dependent ATF5 degradation in hepatocellular carcinoma cells.</title>
<authorList>
<person name="Liu X."/>
<person name="Liu D."/>
<person name="Qian D."/>
<person name="Dai J."/>
<person name="An Y."/>
<person name="Jiang S."/>
<person name="Stanley B."/>
<person name="Yang J."/>
<person name="Wang B."/>
<person name="Liu X."/>
<person name="Liu D.X."/>
</authorList>
<dbReference type="PubMed" id="22528486"/>
<dbReference type="DOI" id="10.1074/jbc.m112.363622"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ATF5</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2012" name="Cancer Res." volume="72" first="5867" last="5877">
<title>DDX31 regulates the p53-HDM2 pathway and rRNA gene transcription through its interaction with NPM1 in renal cell carcinomas.</title>
<authorList>
<person name="Fukawa T."/>
<person name="Ono M."/>
<person name="Matsuo T."/>
<person name="Uehara H."/>
<person name="Miki T."/>
<person name="Nakamura Y."/>
<person name="Kanayama H.O."/>
<person name="Katagiri T."/>
</authorList>
<dbReference type="PubMed" id="23019224"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-12-1645"/>
</citation>
<scope>INTERACTION WITH DDX31</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.015131" last="M111.015131">
<title>Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.</title>
<authorList>
<person name="Bienvenut W.V."/>
<person name="Sumpton D."/>
<person name="Martinez A."/>
<person name="Lilla S."/>
<person name="Espagne C."/>
<person name="Meinnel T."/>
<person name="Giglione C."/>
</authorList>
<dbReference type="PubMed" id="22223895"/>
<dbReference type="DOI" id="10.1074/mcp.m111.015131"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2012" name="Nucleic Acids Res." volume="40" first="4861" last="4878">
<title>Function of homo- and hetero-oligomers of human nucleoplasmin/nucleophosmin family proteins NPM1, NPM2 and NPM3 during sperm chromatin remodeling.</title>
<authorList>
<person name="Okuwaki M."/>
<person name="Sumi A."/>
<person name="Hisaoka M."/>
<person name="Saotome-Nakamura A."/>
<person name="Akashi S."/>
<person name="Nishimura Y."/>
<person name="Nagata K."/>
</authorList>
<dbReference type="PubMed" id="22362753"/>
<dbReference type="DOI" id="10.1093/nar/gks162"/>
</citation>
<scope>INTERACTION WITH NPM3</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4; SER-10; SER-43; SER-70; THR-95; SER-125; SER-139; THR-234; THR-237; SER-242; SER-243; SER-254 AND SER-260</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="72">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-70 AND SER-243</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="73">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-27; LYS-32; LYS-248 AND LYS-250</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="74">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
<title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
<authorList>
<person name="Impens F."/>
<person name="Radoshevich L."/>
<person name="Cossart P."/>
<person name="Ribet D."/>
</authorList>
<dbReference type="PubMed" id="25114211"/>
<dbReference type="DOI" id="10.1073/pnas.1413825111"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-32; LYS-248; LYS-257 AND LYS-267</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="75">
<citation type="journal article" date="2015" name="Am. J. Pathol." volume="185" first="2061" last="2068">
<title>The nucleolar protein GLTSCR2 is an upstream negative regulator of the oncogenic Nucleophosmin-MYC axis.</title>
<authorList>
<person name="Kim J.Y."/>
<person name="Cho Y.E."/>
<person name="Park J.H."/>
</authorList>
<dbReference type="PubMed" id="25956029"/>
<dbReference type="DOI" id="10.1016/j.ajpath.2015.03.016"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH MYC AND NOP53</scope>
</reference>
<reference key="76">
<citation type="journal article" date="2015" name="Cell Rep." volume="10" first="1778" last="1791">
<title>SUMO-2 orchestrates chromatin modifiers in response to DNA damage.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Treffers L.W."/>
<person name="Verlaan-de Vries M."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25772364"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.02.033"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-32 AND LYS-215</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="77">
<citation type="journal article" date="2015" name="J. Cell. Mol. Med." volume="19" first="1245" last="1252">
<title>GLTSCR2 is an upstream negative regulator of nucleophosmin in cervical cancer.</title>
<authorList>
<person name="Kim J.Y."/>
<person name="Cho Y.E."/>
<person name="An Y.M."/>
<person name="Kim S.H."/>
<person name="Lee Y.G."/>
<person name="Park J.H."/>
<person name="Lee S."/>
</authorList>
<dbReference type="PubMed" id="25818168"/>
<dbReference type="DOI" id="10.1111/jcmm.12474"/>
</citation>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="78">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.o114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-32</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="79">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="80">
<citation type="journal article" date="2017" name="Mol. Cell">
<title>Serine ADP-ribosylation depends on HPF1.</title>
<authorList>
<person name="Bonfiglio J.J."/>
<person name="Fontana P."/>
<person name="Zhang Q."/>
<person name="Colby T."/>
<person name="Gibbs-Seymour I."/>
<person name="Atanassov I."/>
<person name="Bartlett E."/>
<person name="Zaja R."/>
<person name="Ahel I."/>
<person name="Matic I."/>
</authorList>
<dbReference type="PubMed" id="28190768"/>
<dbReference type="DOI" id="10.1016/j.molcel.2017.01.003"/>
</citation>
<scope>ADP-RIBOSYLATION AT SER-207</scope>
</reference>
<reference key="81">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-32; LYS-141; LYS-150; LYS-215; LYS-248; LYS-250; LYS-257; LYS-263; LYS-267 AND LYS-273</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="82">
<citation type="journal article" date="2007" name="Proteins" volume="69" first="672" last="678">
<title>Crystal structure of human nucleophosmin-core reveals plasticity of the pentamer-pentamer interface.</title>
<authorList>
<person name="Lee H.H."/>
<person name="Kim H.S."/>
<person name="Kang J.Y."/>
<person name="Lee B.I."/>
<person name="Ha J.Y."/>
<person name="Yoon H.J."/>
<person name="Lim S.O."/>
<person name="Jung G."/>
<person name="Suh S.W."/>
</authorList>
<dbReference type="PubMed" id="17879352"/>
<dbReference type="DOI" id="10.1002/prot.21504"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.75 ANGSTROMS) OF 9-124</scope>
</reference>
<reference key="83">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="23326" last="23332">
<title>Structural consequences of nucleophosmin mutations in acute myeloid leukemia.</title>
<authorList>
<person name="Grummitt C.G."/>
<person name="Townsley F.M."/>
<person name="Johnson C.M."/>
<person name="Warren A.J."/>
<person name="Bycroft M."/>
</authorList>
<dbReference type="PubMed" id="18511415"/>
<dbReference type="DOI" id="10.1074/jbc.m801706200"/>
</citation>
<scope>STRUCTURE BY NMR OF 243-294</scope>
<scope>MUTAGENESIS OF LYS-248; LYS-250; PHE-268; PHE-276; TRP-288 AND TRP-290</scope>
</reference>
<comment type="function">
<text evidence="30 37 38 42 44 50 52 53 55 58">Involved in diverse cellular processes such as ribosome biogenesis, centrosome duplication, protein chaperoning, histone assembly, cell proliferation, and regulation of tumor suppressors p53/TP53 and ARF. Binds ribosome presumably to drive ribosome nuclear export. Associated with nucleolar ribonucleoprotein structures and bind single-stranded nucleic acids. Acts as a chaperonin for the core histones H3, H2B and H4. Stimulates APEX1 endonuclease activity on apurinic/apyrimidinic (AP) double-stranded DNA but inhibits APEX1 endonuclease activity on AP single-stranded RNA. May exert a control of APEX1 endonuclease activity within nucleoli devoted to repair AP on rDNA and the removal of oxidized rRNA molecules. In concert with BRCA2, regulates centrosome duplication. Regulates centriole duplication: phosphorylation by PLK2 is able to trigger centriole replication. Negatively regulates the activation of EIF2AK2/PKR and suppresses apoptosis through inhibition of EIF2AK2/PKR autophosphorylation. Antagonizes the inhibitory effect of ATF5 on cell proliferation and relieves ATF5-induced G2/M blockade (PubMed:22528486). In complex with MYC enhances the transcription of MYC target genes (PubMed:25956029).</text>
</comment>
<comment type="subunit">
<text evidence="25 30 33 35 38 39 40 43 44 46 47 48 51 52 53 54 55 56 57 58">Decamer formed by two pentameric rings associated in a head-to-head fashion (By similarity). Disulfide-linked dimers under certain conditions (PubMed:25818168). The SWAP complex consists of NPM1, NCL, PARP1 and SWAP70 (By similarity). Interacts with NSUN2 and SENP3. Interacts with the methylated form of RPS10. Interacts (via N-terminal domain) with APEX1; the interaction is RNA-dependent and decreases in hydrogen peroxide-damaged cells. Interacts with isoform 1 of NEK2. Interacts with ROCK2 and BRCA2. Interacts with RPGR. Interacts with CENPW. Interacts with EIF2AK2/PKR. Interacts with CEBPA (isoform 4) (PubMed:20075868). Interacts with DDX31; this interaction prevents interaction between NPM1 and HDM2 (PubMed:23019224). Interacts with MYC; competitive with NOP53 (PubMed:25956029). Interacts with NOP53; the interaction is direct and competitive with MYC (PubMed:25956029). Interacts with LRRC34 (By similarity). Interacts with RRP1B (PubMed:19710015, PubMed:20926688). Interacts with NPM3 (PubMed:22362753).</text>
</comment>
<comment type="subunit">
<text evidence="28">(Microbial infection) Interacts with hepatitis delta virus S-HDAg.</text>
</comment>
<comment type="subunit">
<text evidence="61">(Microbial infection) Interacts with HTLV1 Rex protein (via N-terminal nuclear localization signal).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78579">
<id>P06748</id>
</interactant>
<interactant intactId="EBI-448680">
<id>O14965</id>
<label>AURKA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78579">
<id>P06748</id>
</interactant>
<interactant intactId="EBI-624291">
<id>Q96GD4</id>
<label>AURKB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78579">
<id>P06748</id>
</interactant>
<interactant intactId="EBI-625922">
<id>Q8N726</id>
<label>CDKN2A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78579">
<id>P06748</id>
</interactant>
<interactant intactId="EBI-3904738">
<id>P10176</id>
<label>COX8A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78579">
<id>P06748</id>
</interactant>
<interactant intactId="EBI-347859">
<id>Q10570</id>
<label>CPSF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78579">
<id>P06748</id>
</interactant>
<interactant intactId="EBI-640775">
<id>P19525</id>
<label>EIF2AK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78579">
<id>P06748</id>
</interactant>
<interactant intactId="EBI-301834">
<id>Q13547</id>
<label>HDAC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78579">
<id>P06748</id>
</interactant>
<interactant intactId="EBI-301821">
<id>Q92769</id>
<label>HDAC2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78579">
<id>P06748</id>
</interactant>
<interactant intactId="EBI-3916399">
<id>Q9BXL5</id>
<label>HEMGN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78579">
<id>P06748</id>
</interactant>
<interactant intactId="EBI-2878091">
<id>Q71RC2</id>
<label>LARP4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78579">
<id>P06748</id>
</interactant>
<interactant intactId="EBI-389668">
<id>Q00987</id>
<label>MDM2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78579">
<id>P06748</id>
</interactant>
<interactant intactId="EBI-6916466">
<id>Q9BZQ8</id>
<label>NIBAN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78579">
<id>P06748</id>
</interactant>
<interactant intactId="EBI-6658150">
<id>Q86SE8</id>
<label>NPM2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78579">
<id>P06748</id>
</interactant>
<interactant intactId="EBI-12193061">
<id>Q86SE8-2</id>
<label>NPM2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78579">
<id>P06748</id>
</interactant>
<interactant intactId="EBI-716449">
<id>Q8IZL8</id>
<label>PELP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78579">
<id>P06748</id>
</interactant>
<interactant intactId="EBI-721782">
<id>Q96BK5</id>
<label>PINX1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78579">
<id>P06748</id>
</interactant>
<interactant intactId="EBI-356625">
<id>P62753</id>
<label>RPS6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78579">
<id>P06748</id>
</interactant>
<interactant intactId="EBI-2880236">
<id>Q9H4L4</id>
<label>SENP3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78579">
<id>P06748</id>
</interactant>
<interactant intactId="EBI-1772203">
<id>O14746</id>
<label>TERT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78579">
<id>P06748</id>
</interactant>
<interactant intactId="EBI-347351">
<id>P05549</id>
<label>TFAP2A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78579">
<id>P06748</id>
</interactant>
<interactant intactId="EBI-366083">
<id>P04637</id>
<label>TP53</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78579">
<id>P06748</id>
</interactant>
<interactant intactId="EBI-347088">
<id>P63104</id>
<label>YWHAZ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78579">
<id>P06748</id>
</interactant>
<interactant intactId="EBI-7481199">
<id>P24938</id>
<label>L2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78579">
<id>P06748</id>
</interactant>
<interactant intactId="EBI-7481182">
<id>P68951</id>
<label>L2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78579">
<id>P06748</id>
</interactant>
<interactant intactId="EBI-10042882">
<id>P0DOE7</id>
<label>M</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78579">
<id>P06748</id>
</interactant>
<interactant intactId="EBI-25616456">
<id>Q6UPD4</id>
<label>NP</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78579">
<id>P06748</id>
</interactant>
<interactant intactId="EBI-9081051">
<id>B1Q2W9</id>
<label>pre-C/C</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-78579">
<id>P06748</id>
</interactant>
<interactant intactId="EBI-626601">
<id>Q98147</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354150">
<id>P06748-1</id>
</interactant>
<interactant intactId="EBI-15826012">
<id>P49450-1</id>
<label>CENPA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354150">
<id>P06748-1</id>
</interactant>
<interactant intactId="EBI-80140">
<id>P63165</id>
<label>SUMO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354150">
<id>P06748-1</id>
</interactant>
<interactant intactId="EBI-366083">
<id>P04637</id>
<label>TP53</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354150">
<id>P06748-1</id>
</interactant>
<interactant intactId="EBI-308443">
<id>Q14669</id>
<label>TRIP12</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354154">
<id>P06748-2</id>
</interactant>
<interactant intactId="EBI-12193061">
<id>Q86SE8-2</id>
<label>NPM2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="45 55 57 58">Nucleus</location>
<location evidence="45 55 57 58">Nucleolus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="57">Nucleus</location>
<location evidence="57">Nucleoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="31">Cytoplasm</location>
<location evidence="31">Cytoskeleton</location>
<location evidence="31">Microtubule organizing center</location>
<location evidence="31">Centrosome</location>
</subcellularLocation>
<text>Generally nucleolar, but is translocated to the nucleoplasm in case of serum starvation or treatment with anticancer drugs. Has been found in the cytoplasm in patients with primary acute myelogenous leukemia (AML), but not with secondary AML. Can shuttle between cytoplasm and nucleus. Co- localizes with the methylated form of RPS10 in the granular component (GC) region of the nucleolus. Colocalized with nucleolin and APEX1 in nucleoli. Isoform 1 of NEK2 is required for its localization to the centrosome during mitosis.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P06748-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P06748-2</id>
<name>2</name>
<sequence type="described" ref="VSP_003616"/>
</isoform>
<isoform>
<id>P06748-3</id>
<name>3</name>
<sequence type="described" ref="VSP_043599"/>
</isoform>
</comment>
<comment type="PTM">
<text evidence="37 65">Acetylated at C-terminal lysine residues, thereby increasing affinity to histones.</text>
</comment>
<comment type="PTM">
<text>ADP-ribosylated.</text>
</comment>
<comment type="PTM">
<text evidence="27 29 30 32 33 49 50 65">Phosphorylated at Ser-4 by PLK1 and PLK2. Phosphorylation at Ser-4 by PLK2 in S phase is required for centriole duplication and is sufficient to trigger centriole replication. Phosphorylation at Ser-4 by PLK1 takes place during mitosis. Phosphorylated by CDK2 at Ser-125 and Thr-199. Phosphorylation at Thr-199 may trigger initiation of centrosome duplication. Phosphorylated by CDK1 at Thr-199, Thr-219, Thr-234 and Thr-237 during cell mitosis. When these four sites are phosphorated, RNA-binding activity seem to be abolished. May be phosphorylated at Ser-70 by NEK2. The Thr-199 phosphorylated form has higher affinity for ROCK2. CDK6 triggers Thr-199 phosphorylation when complexed to Kaposi's sarcoma herpesvirus (KSHV) V-cyclin, leading to viral reactivation by reducing viral LANA levels.</text>
</comment>
<comment type="PTM">
<text evidence="36">Sumoylated by ARF.</text>
</comment>
<comment type="PTM">
<text evidence="45 57">Ubiquitinated. Ubiquitination leads to proteasomal degradation. Deubiquitinated by USP36 (PubMed:19208757).</text>
</comment>
<comment type="disease">
<text evidence="60 64">A chromosomal aberration involving NPM1 is found in a form of non-Hodgkin lymphoma. Translocation t(2;5)(p23;q35) with ALK. The resulting chimeric NPM1-ALK protein homodimerize and the kinase becomes constitutively activated.</text>
</comment>
<comment type="disease">
<text evidence="62">A chromosomal aberration involving NPM1 is found in a form of acute promyelocytic leukemia. Translocation t(5;17)(q32;q11) with RARA.</text>
</comment>
<comment type="disease">
<text evidence="63">A chromosomal aberration involving NPM1 is a cause of myelodysplastic syndrome (MDS). Translocation t(3;5)(q25.1;q34) with MLF1.</text>
</comment>
<comment type="disease">
<text evidence="34">Defects in NPM1 are associated with acute myelogenous leukemia (AML). Mutations in exon 12 affecting the C-terminus of the protein are associated with an aberrant cytoplasmic location.</text>
</comment>
<comment type="similarity">
<text evidence="68">Belongs to the nucleoplasmin family.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/NPM1ID22.html"/>
</comment>
<dbReference type="EMBL" id="M23613">
<property type="protein sequence ID" value="AAA36380.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M28699">
<property type="protein sequence ID" value="AAA58386.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M26697">
<property type="protein sequence ID" value="AAA36385.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U89321">
<property type="protein sequence ID" value="AAB94739.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U89309">
<property type="protein sequence ID" value="AAB94739.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U89310">
<property type="protein sequence ID" value="AAB94739.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U89311">
<property type="protein sequence ID" value="AAB94739.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U89313">
<property type="protein sequence ID" value="AAB94739.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U89314">
<property type="protein sequence ID" value="AAB94739.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U89317">
<property type="protein sequence ID" value="AAB94739.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U89319">
<property type="protein sequence ID" value="AAB94739.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AB042278">
<property type="protein sequence ID" value="BAB40600.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY740634">
<property type="protein sequence ID" value="AAW67752.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY740635">
<property type="protein sequence ID" value="AAW67753.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY740636">
<property type="protein sequence ID" value="AAW67754.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY740637">
<property type="protein sequence ID" value="AAW67755.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY740638">
<property type="protein sequence ID" value="AAW67756.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY740639">
<property type="protein sequence ID" value="AAW67757.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY740640">
<property type="protein sequence ID" value="AAW67758.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ303464">
<property type="protein sequence ID" value="ABC40399.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY347529">
<property type="protein sequence ID" value="AAQ24860.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BT007011">
<property type="protein sequence ID" value="AAP35657.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK290652">
<property type="protein sequence ID" value="BAF83341.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB451236">
<property type="protein sequence ID" value="BAG70050.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB451361">
<property type="protein sequence ID" value="BAG70175.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471062">
<property type="protein sequence ID" value="EAW61443.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471062">
<property type="protein sequence ID" value="EAW61446.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC002398">
<property type="protein sequence ID" value="AAH02398.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC008495">
<property type="protein sequence ID" value="AAH08495.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC009623">
<property type="protein sequence ID" value="AAH09623.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC012566">
<property type="protein sequence ID" value="AAH12566.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC014349">
<property type="protein sequence ID" value="AAH14349.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC016716">
<property type="protein sequence ID" value="AAH16716.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC016768">
<property type="protein sequence ID" value="AAH16768.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC016824">
<property type="protein sequence ID" value="AAH16824.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC021668">
<property type="protein sequence ID" value="AAH21668.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC021983">
<property type="protein sequence ID" value="AAH21983.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC050628">
<property type="protein sequence ID" value="AAH50628.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC107754">
<property type="protein sequence ID" value="AAI07755.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U41742">
<property type="protein sequence ID" value="AAB00112.1"/>
<property type="status" value="ALT_TERM"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U41743">
<property type="protein sequence ID" value="AAB00113.1"/>
<property type="status" value="ALT_TERM"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U04946">
<property type="protein sequence ID" value="AAA58698.1"/>
<property type="status" value="ALT_TERM"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D45915">
<property type="protein sequence ID" value="BAA08343.1"/>
<property type="status" value="ALT_TERM"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X16934">
<property type="protein sequence ID" value="CAA34809.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="J02590">
<property type="protein sequence ID" value="AAA36473.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M31004">
<property type="protein sequence ID" value="AAA36474.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS43399.1">
<molecule id="P06748-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS4376.1">
<molecule id="P06748-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS4377.1">
<molecule id="P06748-2"/>
</dbReference>
<dbReference type="PIR" id="A33423">
<property type="entry name" value="A32915"/>
</dbReference>
<dbReference type="PIR" id="I38491">
<property type="entry name" value="I38491"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001032827.1">
<molecule id="P06748-3"/>
<property type="nucleotide sequence ID" value="NM_001037738.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002511.1">
<molecule id="P06748-1"/>
<property type="nucleotide sequence ID" value="NM_002520.6"/>
</dbReference>
<dbReference type="RefSeq" id="NP_954654.1">
<molecule id="P06748-2"/>
<property type="nucleotide sequence ID" value="NM_199185.3"/>
</dbReference>
<dbReference type="PDB" id="2LLH">
<property type="method" value="NMR"/>
<property type="chains" value="A=225-294"/>
</dbReference>
<dbReference type="PDB" id="2P1B">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.75"/>
<property type="chains" value="A/B/C/D/E/F/G/H/I/J=9-122"/>
</dbReference>
<dbReference type="PDB" id="2VXD">
<property type="method" value="NMR"/>
<property type="chains" value="A=243-294"/>
</dbReference>
<dbReference type="PDB" id="5EHD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.55"/>
<property type="chains" value="A/B/C/D/E/F/G/H/I/J/a/b/c/d/e/f/g/h/i/j=9-124"/>
</dbReference>
<dbReference type="PDBsum" id="2LLH"/>
<dbReference type="PDBsum" id="2P1B"/>
<dbReference type="PDBsum" id="2VXD"/>
<dbReference type="PDBsum" id="5EHD"/>
<dbReference type="BMRB" id="P06748"/>
<dbReference type="SMR" id="P06748"/>
<dbReference type="BioGRID" id="110929">
<property type="interactions" value="665"/>
</dbReference>
<dbReference type="CORUM" id="P06748"/>
<dbReference type="DIP" id="DIP-30932N"/>
<dbReference type="IntAct" id="P06748">
<property type="interactions" value="420"/>
</dbReference>
<dbReference type="MINT" id="P06748"/>
<dbReference type="STRING" id="9606.ENSP00000296930"/>
<dbReference type="BindingDB" id="P06748"/>
<dbReference type="ChEMBL" id="CHEMBL5178"/>
<dbReference type="DrugBank" id="DB11638">
<property type="generic name" value="Artenimol"/>
</dbReference>
<dbReference type="DrugCentral" id="P06748"/>
<dbReference type="iPTMnet" id="P06748"/>
<dbReference type="MetOSite" id="P06748"/>
<dbReference type="PhosphoSitePlus" id="P06748"/>
<dbReference type="SwissPalm" id="P06748"/>
<dbReference type="BioMuta" id="NPM1"/>
<dbReference type="DMDM" id="114762"/>
<dbReference type="DOSAC-COBS-2DPAGE" id="P06748"/>
<dbReference type="REPRODUCTION-2DPAGE" id="IPI00549248"/>
<dbReference type="SWISS-2DPAGE" id="P06748"/>
<dbReference type="EPD" id="P06748"/>
<dbReference type="jPOST" id="P06748"/>
<dbReference type="MassIVE" id="P06748"/>
<dbReference type="MaxQB" id="P06748"/>
<dbReference type="PaxDb" id="P06748"/>
<dbReference type="PeptideAtlas" id="P06748"/>
<dbReference type="PRIDE" id="P06748"/>
<dbReference type="ProteomicsDB" id="51927">
<molecule id="P06748-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="51928">
<molecule id="P06748-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="51929">
<molecule id="P06748-3"/>
</dbReference>
<dbReference type="TopDownProteomics" id="P06748-1">
<molecule id="P06748-1"/>
</dbReference>
<dbReference type="TopDownProteomics" id="P06748-2">
<molecule id="P06748-2"/>
</dbReference>
<dbReference type="TopDownProteomics" id="P06748-3">
<molecule id="P06748-3"/>
</dbReference>
<dbReference type="Antibodypedia" id="1828">
<property type="antibodies" value="1222 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="4869"/>
<dbReference type="Ensembl" id="ENST00000296930">
<molecule id="P06748-1"/>
<property type="protein sequence ID" value="ENSP00000296930"/>
<property type="gene ID" value="ENSG00000181163"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000351986">
<molecule id="P06748-2"/>
<property type="protein sequence ID" value="ENSP00000341168"/>
<property type="gene ID" value="ENSG00000181163"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000393820">
<molecule id="P06748-3"/>
<property type="protein sequence ID" value="ENSP00000377408"/>
<property type="gene ID" value="ENSG00000181163"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000517671">
<molecule id="P06748-1"/>
<property type="protein sequence ID" value="ENSP00000428755"/>
<property type="gene ID" value="ENSG00000181163"/>
</dbReference>
<dbReference type="GeneID" id="4869"/>
<dbReference type="KEGG" id="hsa:4869"/>
<dbReference type="UCSC" id="uc003mbh.4">
<molecule id="P06748-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="4869"/>
<dbReference type="DisGeNET" id="4869"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000181163.13"/>
<dbReference type="GeneCards" id="NPM1"/>
<dbReference type="HGNC" id="HGNC:7910">
<property type="gene designation" value="NPM1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000181163">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="NPM1"/>
<dbReference type="MIM" id="164040">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P06748"/>
<dbReference type="OpenTargets" id="ENSG00000181163"/>
<dbReference type="Orphanet" id="98834">
<property type="disease" value="Acute myeloblastic leukemia with maturation"/>
</dbReference>
<dbReference type="Orphanet" id="98833">
<property type="disease" value="Acute myeloblastic leukemia without maturation"/>
</dbReference>
<dbReference type="Orphanet" id="402026">
<property type="disease" value="Acute myeloid leukemia with NPM1 somatic mutations"/>
</dbReference>
<dbReference type="Orphanet" id="520">
<property type="disease" value="Acute promyelocytic leukemia"/>
</dbReference>
<dbReference type="Orphanet" id="1775">
<property type="disease" value="Dyskeratosis congenita"/>
</dbReference>
<dbReference type="Orphanet" id="98842">
<property type="disease" value="Lymphomatoid papulosis"/>
</dbReference>
<dbReference type="Orphanet" id="300865">
<property type="disease" value="Primary cutaneous anaplastic large cell lymphoma"/>
</dbReference>
<dbReference type="PharmGKB" id="PA31712"/>
<dbReference type="eggNOG" id="KOG0488">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000153052"/>
<dbReference type="HOGENOM" id="CLU_058838_0_0_1"/>
<dbReference type="InParanoid" id="P06748"/>
<dbReference type="KO" id="K11276"/>
<dbReference type="OMA" id="VEACICS"/>
<dbReference type="PhylomeDB" id="P06748"/>
<dbReference type="TreeFam" id="TF327704"/>
<dbReference type="PathwayCommons" id="P06748"/>
<dbReference type="Reactome" id="R-HSA-180746">
<property type="pathway name" value="Nuclear import of Rev protein"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3899300">
<property type="pathway name" value="SUMOylation of transcription cofactors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-606279">
<property type="pathway name" value="Deposition of new CENPA-containing nucleosomes at the centromere"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804115">
<property type="pathway name" value="TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8869496">
<property type="pathway name" value="TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation"/>
</dbReference>
<dbReference type="SIGNOR" id="P06748"/>
<dbReference type="BioGRID-ORCS" id="4869">
<property type="hits" value="509 hits in 856 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="NPM1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P06748"/>
<dbReference type="GeneWiki" id="NPM1"/>
<dbReference type="GenomeRNAi" id="4869"/>
<dbReference type="Pharos" id="P06748">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P06748"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 5"/>
</dbReference>
<dbReference type="RNAct" id="P06748">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000181163">
<property type="expression patterns" value="Expressed in kidney and 227 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P06748">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P06748">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005813">
<property type="term" value="C:centrosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005925">
<property type="term" value="C:focal adhesion"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0032993">
<property type="term" value="C:protein-DNA complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:1990904">
<property type="term" value="C:ribonucleoprotein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0031616">
<property type="term" value="C:spindle pole centrosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033613">
<property type="term" value="F:activating transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0001046">
<property type="term" value="F:core promoter sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0042393">
<property type="term" value="F:histone binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051059">
<property type="term" value="F:NF-kappaB binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004860">
<property type="term" value="F:protein kinase inhibitor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043023">
<property type="term" value="F:ribosomal large subunit binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0043024">
<property type="term" value="F:ribosomal small subunit binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030957">
<property type="term" value="F:Tat protein binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003713">
<property type="term" value="F:transcription coactivator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051082">
<property type="term" value="F:unfolded protein binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007569">
<property type="term" value="P:cell aging"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034644">
<property type="term" value="P:cellular response to UV"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0034080">
<property type="term" value="P:CENP-A containing nucleosome assembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007098">
<property type="term" value="P:centrosome cycle"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006338">
<property type="term" value="P:chromatin remodeling"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006281">
<property type="term" value="P:DNA repair"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006886">
<property type="term" value="P:intracellular protein transport"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010826">
<property type="term" value="P:negative regulation of centrosome duplication"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044387">
<property type="term" value="P:negative regulation of protein kinase activity by regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006913">
<property type="term" value="P:nucleocytoplasmic transport"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006334">
<property type="term" value="P:nucleosome assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902751">
<property type="term" value="P:positive regulation of cell cycle G2/M phase transition"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045727">
<property type="term" value="P:positive regulation of translation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008104">
<property type="term" value="P:protein localization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046599">
<property type="term" value="P:regulation of centriole replication"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010824">
<property type="term" value="P:regulation of centrosome duplication"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0060735">
<property type="term" value="P:regulation of eIF2 alpha phosphorylation by dsRNA"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032071">
<property type="term" value="P:regulation of endodeoxyribonuclease activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060699">
<property type="term" value="P:regulation of endoribonuclease activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902629">
<property type="term" value="P:regulation of mRNA stability involved in cellular response to UV"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042273">
<property type="term" value="P:ribosomal large subunit biogenesis"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0000055">
<property type="term" value="P:ribosomal large subunit export from nucleus"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042274">
<property type="term" value="P:ribosomal small subunit biogenesis"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0000056">
<property type="term" value="P:ribosomal small subunit export from nucleus"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042255">
<property type="term" value="P:ribosome assembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006407">
<property type="term" value="P:rRNA export from nucleus"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="DisProt" id="DP01474"/>
<dbReference type="Gene3D" id="1.10.10.2100">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00295"/>
<dbReference type="InterPro" id="IPR038101">
<property type="entry name" value="NPM1_C_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR004301">
<property type="entry name" value="Nucleoplasmin"/>
</dbReference>
<dbReference type="InterPro" id="IPR024057">
<property type="entry name" value="Nucleoplasmin_core_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036824">
<property type="entry name" value="Nucleoplasmin_core_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR22747">
<property type="entry name" value="PTHR22747"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF03066">
<property type="entry name" value="Nucleoplasmin"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF69203">
<property type="entry name" value="SSF69203"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0013">ADP-ribosylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0143">Chaperone</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0694">RNA-binding</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Nucleophosmin" id="PRO_0000219481">
<location>
<begin position="1"/>
<end position="294"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with SENP3">
<location>
<begin position="1"/>
<end position="186"/>
</location>
</feature>
<feature type="region of interest" description="Necessary for interaction with APEX1" evidence="44">
<location>
<begin position="1"/>
<end position="117"/>
</location>
</feature>
<feature type="region of interest" description="Required for nucleolar localization">
<location>
<begin position="243"/>
<end position="294"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="26">
<location>
<begin position="152"/>
<end position="157"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="26">
<location>
<begin position="191"/>
<end position="197"/>
</location>
</feature>
<feature type="compositionally biased region" description="Met-rich">
<location>
<begin position="1"/>
<end position="9"/>
</location>
</feature>
<feature type="compositionally biased region" description="Asp/Glu-rich (acidic)">
<location>
<begin position="120"/>
<end position="132"/>
</location>
</feature>
<feature type="compositionally biased region" description="Asp/Glu-rich (highly acidic)">
<location>
<begin position="161"/>
<end position="188"/>
</location>
</feature>
<feature type="site" description="Interaction between pentamers" evidence="24">
<location>
<position position="55"/>
</location>
</feature>
<feature type="site" description="Interaction between pentamers" evidence="24">
<location>
<position position="80"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form NPM1-MLF1" evidence="63">
<location>
<begin position="175"/>
<end position="176"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylmethionine" evidence="11 14 15 16 65">
<location>
<position position="1"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PLK1 and PLK2" evidence="14 15 17 32 50">
<location>
<position position="4"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14 17">
<location>
<position position="10"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="12">
<location>
<position position="32"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17">
<location>
<position position="43"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="25">
<location>
<position position="67"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 5 6 8 9 13 14 15 17 18">
<location>
<position position="70"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="8">
<location>
<position position="75"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="4 8 14 17">
<location>
<position position="95"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK2" evidence="6 7 8 9 10 13 14 15 17 65">
<location>
<position position="125"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="137"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 14 17">
<location>
<position position="139"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="3 12">
<location>
<position position="150"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="3">
<location>
<position position="154"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CDK1, CDK2 and CDK6" evidence="5 14 29 49">
<location>
<position position="199"/>
</location>
</feature>
<feature type="modified residue" description="ADP-ribosylserine" evidence="59">
<location>
<position position="207"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="3 37">
<location>
<position position="212"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CDK1" evidence="69">
<location>
<position position="219"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="227"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="37">
<location>
<position position="229"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="37">
<location>
<position position="230"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CDK1" evidence="8 17">
<location>
<position position="234"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CDK1" evidence="8 17 29">
<location>
<position position="237"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14 17">
<location>
<position position="242"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 14 15 17 18">
<location>
<position position="243"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="37">
<location>
<position position="250"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 15 17">
<location>
<position position="254"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="12 37">
<location>
<position position="257"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14 17">
<location>
<position position="260"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="12">
<location>
<position position="267"/>
</location>
</feature>
<feature type="modified residue" description="N6-succinyllysine; alternate" evidence="25">
<location>
<position position="267"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="12">
<location>
<position position="273"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="6 14">
<location>
<position position="279"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="37">
<location>
<position position="292"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="20">
<location>
<position position="27"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="19">
<location>
<position position="32"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="19 20 21 22 23">
<location>
<position position="32"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="23">
<location>
<position position="141"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="23">
<location>
<position position="150"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="22 23">
<location>
<position position="215"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate">
<location>
<position position="230"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="19">
<location>
<position position="248"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="19 20 23">
<location>
<position position="248"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="20 23">
<location>
<position position="250"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="19">
<location>
<position position="257"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="19 23">
<location>
<position position="257"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate" evidence="36">
<location>
<position position="263"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="23">
<location>
<position position="263"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="19">
<location>
<position position="267"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="23">
<location>
<position position="267"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="23">
<location>
<position position="273"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_003616" evidence="66">
<location>
<begin position="195"/>
<end position="223"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_043599" evidence="66 67">
<original>GGSLPKVEAKFINYVKNCFRMTDQEAIQDLWQWRKSL</original>
<variation>AH</variation>
<location>
<begin position="258"/>
<end position="294"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation by PLK2 and impairs centriole duplication." evidence="50">
<original>S</original>
<variation>A</variation>
<location>
<position position="4"/>
</location>
</feature>
<feature type="mutagenesis site" description="Mimicks phosphorylation state, inducing accumulation of centrioles." evidence="50">
<original>S</original>
<variation>D</variation>
<variation>E</variation>
<location>
<position position="4"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect phosphorylation by PLK2." evidence="50">
<original>T</original>
<variation>A</variation>
<location>
<position position="95"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect phosphorylation by PLK2." evidence="50">
<original>S</original>
<variation>A</variation>
<location>
<position position="125"/>
</location>
</feature>
<feature type="mutagenesis site" description="Partial loss of phosphorylation. Does not affect phosphorylation by PLK2." evidence="29 50">
<original>T</original>
<variation>A</variation>
<location>
<position position="199"/>
</location>
</feature>
<feature type="mutagenesis site" description="Partial loss of phosphorylation." evidence="29">
<original>T</original>
<variation>A</variation>
<location>
<position position="219"/>
</location>
</feature>
<feature type="mutagenesis site" description="Partial loss of phosphorylation; when associated with A-237." evidence="29">
<original>T</original>
<variation>A</variation>
<location>
<position position="234"/>
</location>
</feature>
<feature type="mutagenesis site" description="Partial loss of phosphorylation." evidence="29">
<original>T</original>
<variation>A</variation>
<location>
<position position="237"/>
</location>
</feature>
<feature type="mutagenesis site" description="Partial destabilization of the structure." evidence="41">
<original>K</original>
<variation>A</variation>
<location>
<position position="248"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increase in the stabilization of the structure." evidence="41">
<original>K</original>
<variation>A</variation>
<location>
<position position="250"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increase in the stabilization of the structure and partial delocalization to the nucleoplasm. Complete delocalization to the nucleoplasm; when associated with A-267." evidence="40">
<original>K</original>
<variation>A</variation>
<location>
<position position="263"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in the sumoylation level." evidence="40">
<original>K</original>
<variation>R</variation>
<location>
<position position="263"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increase in the stabilization of the structure and complete delocalization to the nucleoplasm. Complete delocalization to the nucleoplasm; when associated with A-263.">
<original>K</original>
<variation>A</variation>
<location>
<position position="267"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete destabilization of the structure and loss of nucleolus localization; when associated with A-276." evidence="41">
<original>F</original>
<variation>A</variation>
<location>
<position position="268"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete destabilization of the structure and loss of nucleolus localization; when associated with A-268." evidence="41">
<original>F</original>
<variation>A</variation>
<location>
<position position="276"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete destabilization of the structure; when associated with A-290." evidence="41">
<original>W</original>
<variation>A</variation>
<location>
<position position="288"/>
</location>
</feature>
<feature type="mutagenesis site" description="Partial destabilization of the structure. Complete destabilization of the structure; when associated with A-288." evidence="41">
<original>W</original>
<variation>A</variation>
<location>
<position position="290"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 13; AAH21983." ref="13" evidence="68">
<original>K</original>
<variation>E</variation>
<location>
<position position="80"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 22; AA sequence." ref="22" evidence="68">
<original>E</original>
<variation>D</variation>
<location>
<position position="129"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAW67758." ref="6" evidence="68">
<location>
<position position="168"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 13; AAH16768." ref="13" evidence="68">
<original>D</original>
<variation>G</variation>
<location>
<position position="178"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 11; BAG70175/BAG70050." ref="11" evidence="68">
<original>D</original>
<variation>N</variation>
<location>
<position position="183"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 23; AAA36473/AAA36474." ref="23" evidence="68">
<original>D</original>
<variation>P</variation>
<location>
<position position="213"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 21; AA sequence." ref="21" evidence="68">
<original>S</original>
<variation>L</variation>
<location>
<position position="214"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 23; AAA36473." ref="23" evidence="68">
<original>P</original>
<variation>S</variation>
<location>
<position position="216"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 23; AAA36473." ref="23" evidence="68">
<original>TPR</original>
<variation>SSS</variation>
<location>
<begin position="219"/>
<end position="221"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; AAQ24860." ref="8" evidence="68">
<original>Q</original>
<variation>R</variation>
<location>
<position position="231"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 13; AAH16768." ref="13" evidence="68">
<original>Y</original>
<variation>C</variation>
<location>
<position position="271"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 13; AAH12566." ref="13" evidence="68">
<original>L</original>
<variation>F</variation>
<location>
<position position="287"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAW67752/AAW67755." ref="6" evidence="68">
<original>WQWRKSL</original>
<variation>CLAVEEVSLRK</variation>
<location>
<begin position="288"/>
<end position="294"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAW67753 and 7; ABC40399." ref="6 7" evidence="68">
<original>WQWRKSL</original>
<variation>CMAVEEVSLRK</variation>
<location>
<begin position="288"/>
<end position="294"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAW67754." ref="6" evidence="68">
<original>WQWRKSL</original>
<variation>CVAVEEVSLRK</variation>
<location>
<begin position="288"/>
<end position="294"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAW67756." ref="6" evidence="68">
<original>WRKSL</original>
<variation>SLAQVSLRK</variation>
<location>
<begin position="290"/>
<end position="294"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAW67757." ref="6" evidence="68">
<original>WRKSL</original>
<variation>SLEKVSLRK</variation>
<location>
<begin position="290"/>
<end position="294"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="15"/>
<end position="24"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="29"/>
<end position="31"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="40"/>
<end position="49"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="58"/>
<end position="65"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="71"/>
<end position="80"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="81"/>
<end position="83"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="84"/>
<end position="94"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="96"/>
<end position="104"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="109"/>
<end position="117"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="244"/>
<end position="257"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="265"/>
<end position="275"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="281"/>
<end position="292"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location sequence="P06748-3">
<position position="254"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="12">
<location sequence="P06748-3">
<position position="257"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2LLH"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5EHD"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16916647"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17924679"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18220336"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18318008"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22223895"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25114211"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25772364"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000250"/>
<evidence key="25" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q61937"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000255"/>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11051553"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11309377"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12058066"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12882984"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14654843"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15190079"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15388344"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15659725"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15772089"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15897463"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16107701"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17015463"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17215513"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18259216"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18511415"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18809582"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19015314"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19188445"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19208757"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19710015"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20075868"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20159986"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20333249"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20352051"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20926688"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21084279"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22002061"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22362753"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22528486"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23019224"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25818168"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25956029"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28190768"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8122112"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8314759"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8562957"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8570204"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8633037"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source ref="17"/>
</evidence>
<evidence key="66" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000303">
<source ref="5"/>
</evidence>
<evidence key="68" type="ECO:0000305"/>
<evidence key="69" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="12058066"/>
</source>
</evidence>
<sequence length="294" mass="32575" checksum="620BC7BA2E4A0054" modified="1990-11-01" version="2">MEDSMDMDMSPLRPQNYLFGCELKADKDYHFKVDNDENEHQLSLRTVSLGAGAKDELHIVEAEAMNYEGSPIKVTLATLKMSVQPTVSLGGFEITPPVVLRLKCGSGPVHISGQHLVAVEEDAESEDEEEEDVKLLSISGKRSAPGGGSKVPQKKVKLAADEDDDDDDEEDDDEDDDDDDFDDEEAEEKAPVKKSIRDTPAKNAQKSNQNGKDSKPSSTPRSKGQESFKKQEKTPKTPKGPSSVEDIKAKMQASIEKGGSLPKVEAKFINYVKNCFRMTDQEAIQDLWQWRKSL</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

